 |
인쇄하기
취소
|
Hanmi to register a protein related drug patent.
Hanmi announced that a patent registration for the polypeptide combined substance having a sustained physiological activity had been completed.
The patent illustrated a novel technology revealing that a significant increased half life of a protein molecule in the body had been achieved by binding a bio carrier to the targeted protein, which may provide for a certain protein bio drug to act ...
The patent illustrated a novel technology revealing that a significant increased half life of a protein molecule in the body had been achieved by binding a bio carrier to the targeted protein, which may provide for a certain protein bio drug to act ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.